Cargando…

Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs

Detalles Bibliográficos
Autores principales: Hirshberg, Boaz, Raz, Itamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632144/
https://www.ncbi.nlm.nih.gov/pubmed/21525438
http://dx.doi.org/10.2337/dc11-s202
_version_ 1782266847680266240
author Hirshberg, Boaz
Raz, Itamar
author_facet Hirshberg, Boaz
Raz, Itamar
author_sort Hirshberg, Boaz
collection PubMed
description
format Online
Article
Text
id pubmed-3632144
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-36321442013-04-24 Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs Hirshberg, Boaz Raz, Itamar Diabetes Care Diabetes, Obesity and Hypertension Outcome Studies American Diabetes Association 2011-05 2011-04-22 /pmc/articles/PMC3632144/ /pubmed/21525438 http://dx.doi.org/10.2337/dc11-s202 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Diabetes, Obesity and Hypertension Outcome Studies
Hirshberg, Boaz
Raz, Itamar
Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
title Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
title_full Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
title_fullStr Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
title_full_unstemmed Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
title_short Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
title_sort impact of the u.s. food and drug administration cardiovascular assessment requirements on the development of novel antidiabetes drugs
topic Diabetes, Obesity and Hypertension Outcome Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632144/
https://www.ncbi.nlm.nih.gov/pubmed/21525438
http://dx.doi.org/10.2337/dc11-s202
work_keys_str_mv AT hirshbergboaz impactoftheusfoodanddrugadministrationcardiovascularassessmentrequirementsonthedevelopmentofnovelantidiabetesdrugs
AT razitamar impactoftheusfoodanddrugadministrationcardiovascularassessmentrequirementsonthedevelopmentofnovelantidiabetesdrugs